Selective JAK2 pathway inhibition enhances anti-leukemic functionality in CD19 CAR-T cells by Kohei Mitsuno, Masaya Suematsu, Yuki Naito, Azusa Mayumi, Hideki Yoshida, Shinya Osone, Toshihiko Imamura, Yozo Nakazawa, Shigeki Yagyu, Tomoko Iehara

Get full text

Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr) by Chikako Funasaka, Chikako Funasaka, Yoichi Naito, Yoichi Naito, Yoichi Naito, Hitomi Kubota, Yukiko Ishiguro, Nozomu Fuse, Masashi Wakabayashi, Akihiro Sato, Junichiro Yuda, Junichiro Yuda, Genichiro Ishii, Toshihiro Suzuki, Kazumasa Takenouchi, Tetsuya Nakatsura, Konomi Morita, Yoichi Inada, Miyuki Tanaka, Miyuki Tanaka, Miyuki Tanaka, Yozo Nakazawa, Yozo Nakazawa, Shigeki Yagyu, Shigeki Yagyu, Toshihiko Doi

Get full text